The Amsler grid is a simple and effective tool often used to detect early signs of macular degeneration. This is a grid of ...

InflammX’s pipeline includes an orally dosed therapeutic candidate targeting intermediate age-related macular degeneration ...

Another common early symptom is blurry or distorted vision. Straight lines, like those on a doorframe or a tiled floor, may ...

Over the past two decades, the role of vitreomacular adhesion in vitreomacular interface pathologies, such as vitreomacular traction syndrome, epiretinal membrane and macular hole, has been ...

Breakthroughs in age-related macular degeneration (AMD) treatments have revolutionized the management of this progressive and potentially devastating eye disease. These include treatments such as ...

University of California San Diego researchers have identified a U-shaped association between high-density lipoprotein (HDL) ...

"We are enthusiastic about getting patients started in the OCU200 Phase 1 clinical trial and sharing not only safety but ...

The phase 1 clinical trial is a multicenter, open-label, dose-escalation study to assess drug safety via intravitreal ...

High and low levels of high-density lipoprotein and a novel single-nucleotide polymorphism were found to be associated with ...

US-based biotechnology company Ocugen has dosed the first subject in a multicentre Phase I trial of OCU200 for diabetic ...

The following is a summary of “Oral Antioxidant and Lutein/Zeaxanthin Supplements Slow Geographic Atrophy Progression to the ...

InflammX’s pipeline includes an orally dosed therapeutic candidate targeting intermediate age-related macular degeneration (iAMD) and diabetic retinal eye disease. Under the terms of the option ...